A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds.
Levothyroxine — marketed under brand names such as Synthroid — is the second-most commonly prescribed medication among older adults in the US. It’s consumed by about 7% of the US population.
The drug addresses hypothyroidism, also known as an underactive thyroid, by replacing or providing more of a thyroid hormone naturally produced by the body.
The study authors, from Johns Hopkins Medicine, linked levothyroxine use to a greater loss of bone mass and bone density over six years — even in older adults with normal thyroid function.
Read more at https://nypost.com/2024/11/25/lifestyle/popular-thyroid-medication-levothyroxine-linked-to-bone-loss/
#prescriptions #drugscandal #johnhopkins #medication
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Subscribe to New York Post Sports: https://www.youtube.com/c/nypostsports
Catch the latest news here: https://nypost.com/
Follow The New York Post on:
Twitter - https://twitter.com/nypost
Facebook - https://www.facebook.com/NYPost